Business Wire
Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation
📈
AI Sentiment
Highly Positive
9/10
Estrella Immunopharma Inc. News
Latest updates and market news for ESLA
1 news
Nov 30 - Dec 6, 2025
Page 1
Share this news page